We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

110 hedge funds and large institutions have $51.5M invested in Ampio Pharmaceuticals Inc. in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $695K

133% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 15

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

29% more capital invested

Capital invested by funds: $40M → $51.5M (+$11.5M)

7% more funds holding

Funds holding: 103 → 110 (+7)

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
35
Reduced
15
Closed
9
Calls
$2.19M
Puts
$695K
Net Calls
+$1.49M
Net Calls Change
+$1.18M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.81M
2
WIC
Willis Investment Counsel
Georgia
+$1.63M
3
HF
HRT Financial
New York
+$855K
4
BlackRock
BlackRock
New York
+$774K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$756K

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$286K
2
Wells Fargo
Wells Fargo
California
-$257K
3
Capstone Investment Advisors
Capstone Investment Advisors
New York
-$201K
4
Jane Street
Jane Street
New York
-$135K
5
MFS
Mirabella Financial Services
United Kingdom
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIAS
51
Beacon Investment Advisory Services
New Jersey
$68K +$17K +33 +33%
JG
52
Jefferies Group
New York
$63.9K +$65K +126 New
Commonwealth Equity Services
53
Commonwealth Equity Services
Massachusetts
$59K – – –
JWA
54
JFS Wealth Advisors
Pennsylvania
$59K – – –
SSA
55
Schonfeld Strategic Advisors
New York
$58K +$32.5K +63 +121%
Qube Research & Technologies (QRT)
56
Qube Research & Technologies (QRT)
United Kingdom
$57K -$74.3K -144 -56%
CW
57
CreativeOne Wealth
Kansas
$55K +$1.03K +2 +2%
TFS
58
TrustCore Financial Services
Tennessee
$54K -$6.71K -13 -11%
Victory Capital Management
59
Victory Capital Management
Texas
$50K +$1.55K +3 +3%
FHA
60
Flagship Harbor Advisors
Massachusetts
$50K +$12.9K +25 +34%
PCM
61
Prelude Capital Management
New York
$50K +$51.1K +99 New
TRCT
62
Tower Research Capital (TRC)
New York
$49K +$6.71K +13 +16%
Barclays
63
Barclays
United Kingdom
$46K +$46.9K +91 New
MAM
64
Marotta Asset Management
Virginia
$44.4K – – –
TW
65
TrinityPoint Wealth
Connecticut
$44K – – –
OC
66
Oppenheimer & Co
New York
$42K – – –
HAG
67
HighPoint Advisor Group
Illinois
$41K -$15.5K -30 -29%
MFA
68
Mayflower Financial Advisors
Massachusetts
$41K – – –
SBIA
69
Sheaff Brock Investment Advisors
Indiana
$41K – – –
EWA
70
Exencial Wealth Advisors
Oklahoma
$41K +$2.06K +4 +5%
HighTower Advisors
71
HighTower Advisors
Illinois
$41K +$41.3K +80 New
BFG
72
Baron Financial Group
New Jersey
$39.7K – – –
BCM
73
Brookstone Capital Management
Illinois
$36K +$12.4K +24 +51%
Bank of America
74
Bank of America
North Carolina
$36K +$29.4K +57 +380%
WFAG
75
Wescott Financial Advisory Group
Pennsylvania
$35K – – –
1 2
3
4 5

AMPE Hedge Fund Activity: Q1 2021 in Review

110 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2021, worth a combined $51.5M — up 29% from $40M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new AMPE positions and 9 closed out — a net gain of 9 holders — while 35 added to existing stakes and 15 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.81M. The largest seller was Group One Trading, cutting an estimated $286K.

  • 110 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2021, up from 103 in Q4 2020.
  • Funds reported $51.5M of Ampio Pharmaceuticals Inc. stock for Q1 2021, up 29% quarter-over-quarter.
  • 18 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2021 and 9 closed out, a net change of +9 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2021 was Millennium Management, an estimated $2.81M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2021 was Group One Trading, an estimated $286K sold.

Based on aggregated 13F filings for Q1 2021.